G20 health ministers call for equitable, accessible and inclusive healthcare

livemint.com:

clinical trial registries. They also acknowledged the potential of evidence-based T&CM practices in public health delivery systems, provided they are rigorously and scientifically validated to be safe and effective as per WHO TM Strategy 2014-23, extended till 2025," said an official.

“They agreed that there is a need to collaboratively nurture an ecosystem of regional research and development and manufacturing for VTDs, particularly in LMICs, which can support equitable access and distribution, and is tailored to region-specific contexts, to address market failures and regional demand," added the official. The G20 members committed to tackling AMR comprehensively following the One Health approach through strengthening multi-sectoral governance, coordination; research and development (R&D); infection prevention and control (IPC); water, sanitation and hygiene (WASH); improving awareness of AMR; promoting responsible use of antimicrobials including preserving the existing therapeutics across humans, animals and plant sectors through antimicrobial stewardship.